Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c2527 |
|---|---|
| Identifier | NCT03345823 |
| Trial Title | A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Upadacitinib|DRUG: Placebo for Upadacitinib |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Mobile |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-03-21 |
|---|---|
| Primary Completion Date | 2027-09 |
| Completion Date | 2027-09 |